v3.19.3
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash $ 12,308,578 $ 4,450,160
Vendor deposits 430,444 100,000
Prepaid expenses 143,499 78,442
Total current assets 12,882,521 4,628,602
Property and equipment, net 102,043 44,346
Right-to-use assets, net 732,411 0
Other assets:    
Patents, net 369,288 268,796
Trademarks 1,125 850
Prepaid expenses, long term 32,101 0
Deposits 101,839 54,238
Total assets 14,221,328 4,996,832
Current liabilities:    
Accounts payable and accrued expenses, including $9,014 and $32,366 to related parties as of September 30, 2019 and December 31, 2018, respectively 724,450 954,655
Dividends payable 123,601 242,908
Lease liability, short term 365,351 0
Total current liabilities 1,213,402 1,197,563
Lease liability, long term 375,167 0
Total debt 1,588,569 1,197,563
Convertible Preferred Stock 215,000 475,000
Equity:    
Preferred stock 0 0
Common stock, $0.001 par value, authorized 200,000,000 shares, 22,032,342 and 16,868,783 issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 22,032 16,869
Additional paid in capital 101,483,612 74,039,341
Subscriptions 501,000 0
Accumulated deficit (89,994,559) (70,731,941)
Total stockholders' equity attributable to BioSig Technologies, Inc 12,012,085 3,324,269
Non-controlling interest 405,674 0
Total stockholders' equity (deficit) 12,417,759 3,324,269
Total liabilities and stockholders' equity (deficit) $ 14,221,328 $ 4,996,832

Source